Daniel S. Goldman sold Elanco Animal Health (NYSE: ELAN)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in Elanco Animal Health (ELAN) since 2023, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Daniel S. Goldman sold $1,001 - $15,000 of Elanco Animal Health (NYSE: ELAN) on March 6, 2023. Since that trade, ELAN is up +143.45% against the S&P 500 up +88.13%, an outperformance of +55.32%.
Data updated
Daniel S. Goldman's ELAN trades vs the price
ELAN is up +143.45% since Daniel S. Goldman sold on March 6, 2023, versus +88.13% for the S&P 500.
Performance since this trade
All Daniel S. Goldman ELAN trades
Daniel S. Goldman & ELAN trading FAQ
Is it legal for Daniel S. Goldman to trade Elanco Animal Health (ELAN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Elanco Animal Health (ELAN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman sell ELAN?
Daniel S. Goldman disclosed a sale of $1,001 - $15,000 of Elanco Animal Health (ELAN) on March 6, 2023, according to public STOCK Act filings.
How has ELAN performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman sold ELAN on March 6, 2023, the stock is up +143.45%, versus +88.13% for the S&P 500 over the same period, an outperformance of +55.32%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ELAN trades?
Quantellect tracks every disclosed congressional trade in Elanco Animal Health (ELAN) on the Elanco Animal Health congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's ELAN tradesAll congressional filings for Elanco Animal HealthDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.